Short term pharmacological immobilization in macaque monkeys

Area of Science:

• Veterinary Anesthesiology
• Primate Research
• Pharmacology

Background:

• Developing safe immobilization techniques for rhesus monkeys is crucial for research.
• Existing protocols often rely on dissociative anesthetic agents, which can have side effects.
• Non-dissociative anesthetic combinations are needed for improved safety and efficacy.

Purpose of the Study:

• To establish a safe and effective immobilization protocol for rhesus monkeys.
• To evaluate a non-dissociative anesthetic combination for short-term immobilization.
• To assess the recovery profile and side effects of the developed protocol.

Main Methods:

• A prospective, randomized experimental trial was conducted on twenty rhesus monkeys.
• Animals received an intramuscular injection of medetomidine, midazolam, and fentanyl with hyaluronidase.
• Physiological parameters (pulse rate, SpO2) were monitored, and recovery was assessed after atipamezole or placebo administration.

Main Results:

• Full immobilization was achieved within a mean of 269 seconds.
• Mean arterial oxygen saturation remained stable at 94% ± 4% after 10 minutes.
• Recovery time was significantly shorter with atipamezole (2.7 minutes) compared to placebo (55 minutes), with no observed side effects.

Conclusions:

• A combination of midazolam, medetomidine, and fentanyl provides effective and reversible short-term immobilization in rhesus monkeys.
• This protocol is feasible for 20-minute immobilization periods with minimal impact on heart rate.
• The study demonstrates a safe alternative to dissociative anesthetics for rhesus monkey immobilization.